Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy
Open Access
- 1 November 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Nuclear Medicine
- Vol. 40 (11), e496-e500
- https://doi.org/10.1097/rlu.0000000000000841
Abstract
Cho-PET/CT seems to be a promising diagnostic tool in patients who are candidates for radical RT and supporting the decision making in treatment planning, in particular in intermediate-high risk.Keywords
This publication has 19 references indexed in Scilit:
- Choline-PET in prostate cancer management: The point of view of the radiation oncologistCritical Reviews in Oncology/Hematology, 2014
- Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel AtlasInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Choline PET/CT for prostate cancer: Main clinical applicationsEuropean Journal of Radiology, 2011
- Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancerRadiotherapy and Oncology, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2010
- Clinical evidence on PET/CT for radiation therapy planning in prostate cancerRadiotherapy and Oncology, 2010
- Dual-Modality Imaging: Combining Anatomy and FunctionJournal of Nuclear Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Positron emission tomography provides molecular imaging of biological processesProceedings of the National Academy of Sciences, 2000